TrialCell reports. Medicine2023

Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.